Please login to the form below

Not currently logged in
Email:
Password:

Eisai expands in the Middle East with new Dubai office

Japanese pharma company opens regional representative base in Dubai Healthcare City

Eisai EMEA Dubai

Japanese pharma company Eisai has expanded its reach into the Middle East, setting up a new regional representative office in Dubai.

Based in the emirate's Dubai Healthcare City complex, the Eisai EMEA (Europe, Middle East and Africa) Dubai branch office will be led by EMEA regional director Ayman ElDeeb.

“Eisai's entry into the Middle East and Africa region enforces our wider plan of increasing access to medicines based on a strategy of affordability, availability, adoption and architecture,” he said.

“This expansion is an opportunity to make our currently marketed and pipeline products available, as well as to explore in-licensing of products which may match specific patient needs in the region.”

Dubai Healthcare City is home to two hospitals, over 90 outpatient medical centres and diagnostic laboratories with over 2,500 licensed professionals.

From this base Eisai plans to build on the 2009 launch of its peripheral neuropathy treatment Methycobal (mecobalamin) in Saudi Arabia, the United Arab Emirates and other Middle East countries by bringing some of its oncology and neurology products to the region.

These will include the pharma firm's new metastatic breast cancer treatment Halaven (eribulin) as well as a novel agent for the treatment of epilepsy.

Eisai first started doing business in the Middle East in the 1960s, but only started moving away from using local distributors for the region when it opened an office in Bahrain three years ago.

In addition to strengthening its regional presence, the company also hopes to use the new EMEA Dubai office as a base for its entry into certain parts of Africa.

The office also adds to the firm's established EMEA presence, which is centred around its EMEA business headquarters in Hatfield, UK.

Eisai recently expanded the £100m Hatfield facility to take on additional responsibly for operations in the Middle East and Africa, creating a number of new UK jobs.

19th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics